230. Alveolar hypoventilation syndrome Disease details / Clinical trials / Drug dev / DR info
Clinical trials : 6 / Drugs : 7 - (DrugBank : 4) / Drug target genes : 16 - Drug target pathways : 26
Drugs and their primary sponsors and trial info
Acetazolamide
Hospital Son Llatzer
2011 Phase 3 NCT01499485 Spain;
Cerazette
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
- Phase 2 EUCTR2011-000989-35-FR France;
Desogestrel
Assistance Publique - Hôpitaux de Paris
2011 Phase 2/Phase 3 NCT01243697 France;
Children's Hospital Los Angeles
2012 - NCT01500473 United States;
Domperidone
Karolinska Universitetssjukhuset
2006 - EUCTR2005-005950-33-SE Sweden;
Désogestrel
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
- Phase 2 EUCTR2011-000989-35-FR France;
Equal
Philips Respironics
2013 - NCT01964339 United States;
Gold
First Hospital of Peking university
2010 - ChiCTR-DDT-11001215 China;
Ketogenic Diet
Johns Hopkins University
2019 - NCT04108819 United States;
Motilium
Karolinska Universitetssjukhuset
2006 - EUCTR2005-005950-33-SE Sweden;
Hospital Son Llatzer
2011 Phase 3 NCT01499485 Spain;
Cerazette
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
- Phase 2 EUCTR2011-000989-35-FR France;
Desogestrel
Assistance Publique - Hôpitaux de Paris
2011 Phase 2/Phase 3 NCT01243697 France;
Children's Hospital Los Angeles
2012 - NCT01500473 United States;
Domperidone
Karolinska Universitetssjukhuset
2006 - EUCTR2005-005950-33-SE Sweden;
Désogestrel
ASSISTANCE PUBLIQUE - HOPITAUX DE PARIS (AP-HP)
- Phase 2 EUCTR2011-000989-35-FR France;
Equal
Philips Respironics
2013 - NCT01964339 United States;
Gold
First Hospital of Peking university
2010 - ChiCTR-DDT-11001215 China;
Ketogenic Diet
Johns Hopkins University
2019 - NCT04108819 United States;
Motilium
Karolinska Universitetssjukhuset
2006 - EUCTR2005-005950-33-SE Sweden;